Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. [electronic resource]
- International journal of hematology Jan 2017
- 59-69 p. digital
Publication Type: Journal Article
1865-3774
10.1007/s12185-016-2102-3 doi
Adult Androgens--therapeutic use Antineoplastic Agents--therapeutic use Cohort Studies Erythrocyte Transfusion Female Hematopoietic Stem Cell Transplantation Humans Hydroxyurea--therapeutic use Japan--epidemiology Karyotype Male Middle Aged Nitriles Platelet Transfusion Primary Myelofibrosis--diagnosis Prognosis Pyrazoles--therapeutic use Pyrimidines Splenectomy Surveys and Questionnaires Survival Rate Treatment Outcome